Windtree Therapeutics (WINT)
(Delayed Data from NSDQ)
$3.70 USD
-0.12 (-3.14%)
Updated Jul 15, 2024 01:49 PM ET
After-Market: $3.71 +0.01 (0.27%) 5:48 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -8.11 |
EPS Last Quarter | -9.25 |
Last EPS Surprise | NA |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -17.47 |
Next Year | -4.22 |
EPS (TTM) | -67.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -8.11 | -2.27 | -17.47 | -4.22 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -8.11 | -2.27 | -2.38 | -2.13 |
High Estimate | -8.11 | -2.27 | -2.38 | -2.13 |
Low Estimate | -8.11 | -2.27 | -32.55 | -6.30 |
Year ago EPS | -29.50 | -15.47 | -94.24 | -17.47 |
Year over Year Growth Est. | 72.51% | 85.33% | 81.46% | 75.84% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -8.11 | -2.27 | -17.47 | -4.22 |
7 Days Ago | NA | NA | -24.93 | -6.30 |
30 Days Ago | NA | NA | -24.93 | -6.30 |
60 Days Ago | NA | NA | -24.93 | -6.30 |
90 Days Ago | NA | NA | -25.00 | -6.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -8.11 | -2.27 | -2.38 | -2.13 |
Zacks Consensus Estimate | -8.11 | -2.27 | -17.47 | -4.22 |
Earnings ESP | 0.00% | 0.00% | 86.37% | 49.47% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -9.25 | -13.31 | -15.47 | -29.50 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more